DPincus Boards Posted - Profile

Board	Last Post	Posts
Mr Cooper Group Inc (COOP)	01/03/2018 10:47:19 AM	797
Far East Energy Corp. (fka FEECQ)	06/06/2016 02:02:35 PM	1
WMIH Corp Class B Pfd fka WMIHP	01/06/2015 11:09:44 AM	1
Global Tech Ltd (GTLL)	02/21/2014 02:19:51 PM	2
Patriot Coal Corporation (fka PCXCQ)	10/10/2012 03:48:37 PM	32
VLNC: Valence Technology, Inc.(fka VLNCQ)	07/17/2012 03:53:31 PM	10
Washington Mutual Preferred fka WAMPQ	03/24/2012 02:11:19 AM	47
Washington Mutual WAHUQ Trust Prf (fka WAHUQ)	02/14/2012 04:30:06 PM	4
Baron Capital Enterprise Inc (BCAP)	12/17/2011 01:15:47 PM	5
International Consolidated Companies Inc (INCC)	09/16/2011 09:12:18 AM	2
China Wood, Inc (fka CNWD)	09/30/2010 09:06:14 AM	4
Versa Tech USA (fka VRST)	05/28/2010 08:41:36 AM	5
ALERTS, CHARTS, & HOT STOCKS	05/23/2010 01:46:44 AM	1
IHUB Posting Milestones (milestone)	04/26/2010 10:31:50 PM	2
The Hunt for the Next 10 Bagger	02/20/2010 02:23:26 PM	2
Prom Resources Inc (PRMOD)	02/16/2010 09:14:37 AM	8
Washington Mutual Inc pfd K (fka WAMKQ)	12/29/2009 03:00:49 PM	2
Fortress Financial Group fka FFGO	11/24/2009 10:12:48 PM	7
Accredited Business Consolidators Corp (fka ACDU)	11/05/2009 09:18:12 AM	6
Lehman Brothers Preferred Series G (fka LEHGQ)	09/28/2009 09:06:32 AM	2
MOMO'S BREAKOUT BOARD	09/21/2009 07:15:57 AM	2
Momentum Players	09/21/2009 07:15:01 AM	1
Xtreme One Entertainment Inc (XONI)	09/11/2009 09:39:31 AM	6
Brooke Corporation (fka BXXXQ)	08/28/2009 12:06:55 PM	4
Motors Liquidation Company (fka MTLQQ)	06/03/2009 03:25:55 PM	2
Circuit City Group (fka CCTYQ)	01/15/2009 10:05:20 AM	1
Hard to Treat Diseases (HTDS)	01/07/2009 07:55:54 AM	1

Play Episode

5min

Proactive - Interviews for investors

Orion Minerals CEO on Prieska & Okiep DFS milestones as company enters next phase

Orion Minerals Ltd (ASX:ORN, JSE:ORN) managing director and CEO Errol Smart talked with Proactive's Stephen Gunnion about the completion of definitive feasibility studies (DFS) for both the company’s flagship Prieska copper-zinc project and the Flat Mines project at its Okiep copper project. Smart described this as a pivotal moment, noting, “It’s taken us eight years now to put them together… but it's really a great outcome for us.” The studies confirm robust development pathways for both operations in South Africa's Northern Cape, with both projects fully permitted and development-ready. Smart said Orion is in a unique position globally, with capital intensity figures below key industry benchmarks. The combined production profile is expected to deliver 30,000 tonnes of copper annually at around $9,500 per tonne capital intensity, placing the company in the lower quartile of the cost curve. The Prieska project will follow a two-phase development plan, with a modest $25 million start-up operation set to begin production within 13 months, followed by a ramp-up to full-scale output. Smart also confirmed that discussions are underway with strategic partners, including the Industrial Development Corporation and offtake-related financiers. He highlighted that smelters and traders are actively seeking long-term copper supply, saying, “We represent a very interesting opportunity for them, with certainty.” Visit Proactive’s YouTube channel for more company updates and interviews. Don’t forget to like the video, subscribe to the channel, and enable notifications for future content. #OrionMinerals #CopperMining #PrieskaProject #OkiepProject #BaseMetals #MiningInvestment #FeasibilityStudy #SouthAfricaMining #CopperProduction #ZincProduction

Proactive - Interviews for investors

Nextech3D.ai disrupts industry with launch of AI-powered Ecommerce content studio

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce the launch of a new AI-powered feature as part of the company’s Ecommerce AI Studio. The platform utilizes generative AI to create photorealistic lifestyle images and videos of products—such as apparel, accessories, and furniture—being worn, held, or displayed in realistic settings, eliminating the need for traditional photography. Gappelberg highlighted that ToggleStudios, Nextech3D.ai’s AI-driven content creation tool, is designed to help online retailers generate lifestyle content at scale. The platform reduces reliance on costly and time-consuming physical photoshoots, enabling faster content production, lower operating costs, and increased visual output. The new feature will allow users to generate AI-rendered images of apparel on virtual models with varied backgrounds and appearances. Additionally, retailers can visualize accessories, electronics, and other items in realistic usage scenarios, enhancing product presentation for e-commerce. Another major upgrade is the automated generation of product videos and interactive 3D visuals. Using advanced AI, the system simulates lighting, texture, and perspective, ensuring high-quality imagery that closely replicates traditional photography—but in less time and at a lower cost. #nextech3d.al #otcqx #nexcf #cse #ntar #EvanGappelberg #AmazonSellerCentral #3DModeling #AIPhotography #EcommerceInnovation #3DTechnology #LifestylePhotography #ProactiveInterviews #TechInnovation #AmazonPartners#proactiveinvestors #nextech3d.al

Proactive - Interviews for investors

OKYO Pharma achieves key stability milestone for Urcosimod in clinical development

OKYO Pharma CEO Gary Jacob joined Steve Darling from Proactive to share a significant advancement in the company’s ongoing drug development efforts. The company has successfully demonstrated that urcosimod—formerly known as OK-101—remains stable for more than two and a half years in single-use ampoules, which are used for patient administration. This milestone is a crucial step forward in ensuring the long-term viability of the drug as it progresses through clinical trials. Urcosimod is currently being evaluated in a Phase 2b clinical trial, which is a randomized, placebo-controlled, double-masked study involving 48 patients. The trial is focused on assessing the drug’s effectiveness in treating neurotrophic keratopathy (NCP), a serious and progressive degenerative eye disease. Jacob emphasized that achieving success in clinical development extends beyond obtaining positive clinical trial data. A crucial aspect of regulatory approval includes meeting the rigorous Chemistry, Manufacturing, and Controls (CMC) requirements set by the U.S. Food and Drug Administration (FDA). By demonstrating long-term stability, OKYO Pharma has strengthened its regulatory submission package, addressing an essential factor in the drug’s future approval and commercialization. The company recently completed Good Manufacturing Practice (GMP) stability assay testing of single-use ampoules containing urcosimod in an ophthalmic solution. The results were highly promising—ampoules stored under refrigerated conditions maintained stability for over two and a half years, while initial three-month data from samples stored at room temperature showed potency levels at or above 100%. These findings reinforce confidence in urcosimod’s shelf life and its potential for real-world clinical use. As OKYO Pharma continues to advance urcosimod through the regulatory and clinical development process, this stability milestone represents a critical achievement in its journey toward providing an effective tr

Proactive - Interviews for investors

Buru Energy secures strategic deal for LNG development

Buru Energy Ltd CEO Thomas Nador talked with Proactive about the company’s newly announced strategic development agreement with Clean Energy Fuels Australia Pty Ltd (CEFA) to co-develop the Rafael Gas Project. Nador explained that CEFA brings strong midstream and downstream capabilities, backed by I Squared Capital, which manages around $40 billion in assets. "They bring the right credentials, to look after the downstream and midstream elements of the project," he said. Buru, meanwhile, will focus on the upstream side of the Rafael development. The deal is described as a “watershed moment” for the company, as it provides a clear pathway toward developing a long-term gas and condensate business in northwest Western Australia—an area currently dependent on imported energy. Under the agreement, CEFA will fund, build, and operate a small-scale LNG facility on-site, with Buru paying a processing fee over the life of the project. This significantly reduces Buru’s capital exposure to only the upstream infrastructure—namely, two wells, one of which is already in place. A final investment decision is expected in late 2025 or early 2026, with first cash flows anticipated in the second half of 2027. According to Nador, the projected annual free cash flow from the Rafael development is expected to surpass the company’s current market capitalization. For more insights like this, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe, and enable notifications for future updates. #BuruEnergy #RafaelGasProject #LNGDevelopment #AustralianEnergy #CleanEnergy #GasExploration #CEFA #ThomasNador #ProactiveInvestors #ASXEnergy #NaturalGas #EnergyInfrastructure #I2Capital #UpstreamEnergy #MidstreamDevelopment

Followers	22
Posts	957
Boards Moderated	0
Alias Born	02/05/2006

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

DPincus

Join the InvestorsHub Community

Join the InvestorsHub Community

Boards Posted On

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

DPincus

Join the InvestorsHub Community

Join the InvestorsHub Community

Boards Posted On

Go Ad-Free